Welcome to our dedicated page for CoinShares International news (Ticker: $CNSRF), a resource for investors and traders seeking the latest updates and insights on CoinShares International stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CoinShares International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CoinShares International's position in the market.
CoinShares reported its Q1 2024 results, marking its most successful quarter in history. The company experienced a 216% YoY increase in revenue, gains, and other income, reaching £43.9 million. Adjusted EBITDA rose over four times YoY to £34.2 million, and total comprehensive income surged over 11x YoY to £34.1 million.
Key highlights include the acquisition of Valkyrie's ETF business in March 2024, enhancing CoinShares' global presence. The Asset Management division saw strong inflows, particularly from CoinShares Physical. The Capital Markets & Hedge Fund Solutions division delivered strong top-line performance due to vibrant market activity and gains from staking and trading.
The Board approved a new dividend policy, with an annual dividend of 20%-40% of the Group's total comprehensive income.
CoinShares International has published its 2023 Annual Report, showcasing a total revenue of £85.7 million, an adjusted EBITDA of £57.3 million, and a net asset position of £239.2 million as of December 31, 2023. The report highlights the firm's performance in asset management, capital markets, and hedge fund solutions, with a strategic focus on innovation, expansion, and market penetration.